{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:40:19Z","timestamp":1773297619175,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1124\/jpet.105.093104","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T04:48:32Z","timestamp":1137646112000},"page":"852-859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Mesenteric Vasoconstriction and Hindquarters Vasodilatation Accompany the Pressor Actions of Exendin-4 in Conscious Rats"],"prefix":"10.1016","volume":"316","author":[{"given":"Sheila M.","family":"Gardiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie E.","family":"March","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.093104_bib1","doi-asserted-by":"crossref","unstructured":"Baker JG (2005) The selectivity of \u03b2-adrenoceptor antagonists at the human \u03b21, \u03b22 and \u03b23 adrenoceptors. Br J Pharmacol 144: 317-322.","DOI":"10.1038\/sj.bjp.0706048"},{"key":"10.1124\/jpet.105.093104_bib2","doi-asserted-by":"crossref","unstructured":"Ball DI, Brittain RT, Coleman RA, Denyer LH, Jack D, Johnson M, Lunts LH, Nials AT, Sheldrick KE, and Skidmore IF (1991) Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol 104: 665-671.","DOI":"10.1111\/j.1476-5381.1991.tb12486.x"},{"key":"10.1124\/jpet.105.093104_bib3","doi-asserted-by":"crossref","unstructured":"Barrag\u00e1n JM, Eng J, Rodr\u00edguez RE, and Bl\u00e1zquez E (1999) Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. Am J Physiol 277: E784-E791.","DOI":"10.1152\/ajpendo.1999.277.5.E784"},{"key":"10.1124\/jpet.105.093104_bib4","doi-asserted-by":"crossref","unstructured":"Barrag\u00e1n JM, Rodr\u00edguez RE, and Bl\u00e1zquez E (1994) Changes in arterial blood pressure and heart rate by glucagon-like peptide-1-(7-36) amide in rats. Am J Physiol 266: E459-E466.","DOI":"10.1152\/ajpendo.1994.266.3.E459"},{"key":"10.1124\/jpet.105.093104_bib5","doi-asserted-by":"crossref","unstructured":"Barrag\u00e1n JM, Rodr\u00edguez RE, Eng J, and Bl\u00e1zquez E (1996) Interactions of exendin-(9-39) with the effects of glucagon-like peptide-1-(7-36) amide and of exendin-4 on arterial blood pressure and heart rate in rats. Regul Pept 67: 63-68.","DOI":"10.1016\/S0167-0115(96)00113-9"},{"key":"10.1124\/jpet.105.093104_bib6","doi-asserted-by":"crossref","unstructured":"Batin P, Gardiner SM, Compton AM, and Bennett T (1991) Differential regional hemodynamic effects of the non-peptide angiotensin II antagonist, DuP 753, in water-replete and water-deprived Brattleboro rats. Life Sci 48: 733-739.","DOI":"10.1016\/0024-3205(91)90087-R"},{"key":"10.1124\/jpet.105.093104_bib7","doi-asserted-by":"crossref","unstructured":"Bilski AJ, Halliday SE, Fitzgerald JD, and Wale JL (1983) The pharmacology of a \u03b22-selective adrenoceptor antagonist (ICI 118551). J Cardiovasc Pharmacol 5: 430-437.","DOI":"10.1097\/00005344-198305000-00013"},{"key":"10.1124\/jpet.105.093104_bib8","doi-asserted-by":"crossref","unstructured":"Bojanowska E and Stempniak B (2002) Effects of glucagon-like peptide-1 (7-36) amide on neurohypophysial and cardiovascular functions under hypo- or normotensive hypovolaemia in the rat. J Endocr 172: 303-310.","DOI":"10.1677\/joe.0.1720303"},{"key":"10.1124\/jpet.105.093104_bib9","doi-asserted-by":"crossref","unstructured":"Broadley KJ, Williamson KL, and Roach AG (1999) In vivo demonstration of \u03b1-adrenoceptor-mediated positive inotropy in pithed rats: evidence that noradrenaline does not stimulate myocardial \u03b1-adrenoceptors. J Auton Pharmacol 19: 55-63.","DOI":"10.1046\/j.1365-2680.1999.00115.x"},{"key":"10.1124\/jpet.105.093104_bib10","doi-asserted-by":"crossref","unstructured":"Daniel EE, Anvari M, Fox-Threlkeld JET, and McDonald TJ (2002) Local, exendin-(9-39)-insensitive, site of action of GLP-1 in canine ileum. Am J Physiol 283: G595-G602.","DOI":"10.1152\/ajpgi.00110.2002"},{"key":"10.1124\/jpet.105.093104_bib11","doi-asserted-by":"crossref","unstructured":"Drucker DJ (2001) Minireview: the glucagon-like peptides. Endocrinology 142: 521-527.","DOI":"10.1210\/en.142.2.521"},{"key":"10.1124\/jpet.105.093104_bib12","doi-asserted-by":"crossref","unstructured":"Edwards CMB, Todd JF, Ghatei MA, and Bloom SR (1998) Subcutaneous glucagon-like peptide-1 (7-36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects. Clin Sci 96: 719-724.","DOI":"10.1042\/cs0950719"},{"key":"10.1124\/jpet.105.093104_bib13","doi-asserted-by":"crossref","unstructured":"Edwards CMB, Todd JF, Mahmoudi M, Wang Z, Wang RM, Ghatei MA, and Bloom SR (1999) Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes 48: 86-93.","DOI":"10.2337\/diabetes.48.1.86"},{"key":"10.1124\/jpet.105.093104_bib14","doi-asserted-by":"crossref","unstructured":"Gardiner SM, Bennett T, and Compton AM (1988) Regional haemodynamic effects of neuropeptide Y, vasopressin and angiotensin II in conscious, unrestrained, Long-Evans and Brattleboro rats. J Auton Nerv Syst 24: 15-27.","DOI":"10.1016\/0165-1838(88)90131-2"},{"key":"10.1124\/jpet.105.093104_bib15","doi-asserted-by":"crossref","unstructured":"Gardiner SM, Compton AM, and Bennett T (1989) Regional hemodynamic changes following hypovolemia in conscious rats. Am J Physiol 256: R1076-R1083.","DOI":"10.1152\/ajpregu.1989.256.5.R1076"},{"key":"10.1124\/jpet.105.093104_bib16","doi-asserted-by":"crossref","unstructured":"Gardiner SM, March JE, Kemp PA, and Bennett T (2002) Influence of the CB1 receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats. Br J Pharmacol 136: 581-587.","DOI":"10.1038\/sj.bjp.0704750"},{"key":"10.1124\/jpet.105.093104_bib17","doi-asserted-by":"crossref","unstructured":"Gardiner SM, Rakhit T, Kemp PA, March JE, and Bennett T (1994) Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats. Br J Pharmacol 111: 589-597.","DOI":"10.1111\/j.1476-5381.1994.tb14778.x"},{"key":"10.1124\/jpet.105.093104_bib18","doi-asserted-by":"crossref","unstructured":"Golpon HA, Puechner A, Welte T, Wichert PV, and Feddersen CO (2001) Vasorelaxant effect of glucagon-like peptide-(7-36) amide and amylin on the pulmonary circulation of the rat. Regul Pept 102: 81-86.","DOI":"10.1016\/S0167-0115(01)00300-7"},{"key":"10.1124\/jpet.105.093104_bib19","doi-asserted-by":"crossref","unstructured":"Insulander P, Juhlin-Dannfelt A, Freyschuss U, and Vallin H (2004) Electrophysiological effects of salbutamol, a \u03b22-selective agonist. J Cardiovasc Electrophysiol 15: 316-322.","DOI":"10.1046\/j.1540-8167.2004.03105.x"},{"key":"10.1124\/jpet.105.093104_bib20","doi-asserted-by":"crossref","unstructured":"Isbil-Buyukcoskun N and Gulec G (2004) Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin. Regul Pept 118: 33-38.","DOI":"10.1016\/j.regpep.2003.10.025"},{"key":"10.1124\/jpet.105.093104_bib21","doi-asserted-by":"crossref","unstructured":"Kieffer TJ and Habener JF (1999) The glucagon-like peptides. Endocr Rev 20: 876-913.","DOI":"10.1210\/edrv.20.6.0385"},{"key":"10.1124\/jpet.105.093104_bib22","doi-asserted-by":"crossref","unstructured":"Knudsen LB (2004) Glucagon-like peptide-1: the basis of a new class of treatment for type 2 diabetes. J Med Chem 47: 4128-4134.","DOI":"10.1021\/jm030630m"},{"key":"10.1124\/jpet.105.093104_bib23","doi-asserted-by":"crossref","unstructured":"Malendowicz LK, Nussdorfer GG, Nowak KW, Ziolkowska A, Tortorella C, and Trejter M (2003) Exendin-4, a GLP-1 receptor agonist, stimulates pituitary-adrenocortical axis in the rat: investigations into the mechanism(s) underlying Ex4 effect. Int J Mol Med 12: 237-241.","DOI":"10.3892\/ijmm.12.2.237"},{"key":"10.1124\/jpet.105.093104_bib24","doi-asserted-by":"crossref","unstructured":"Martin JR (2005) Peptide YY administration into the posterior hypothalamic nucleus of the rat evokes cardiovascular changes by non-adrenergic, non-cholinergic mechanisms. Auton Autacoid Pharmacol 25: 53-67.","DOI":"10.1111\/j.1474-8673.2004.00331.x"},{"key":"10.1124\/jpet.105.093104_bib25","doi-asserted-by":"crossref","unstructured":"Nystr\u00f6m T, Gonon AT, Sj\u00f6holm \u00c5, and Pernow J (2005) Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism. Regul Pept 125: 173-177.","DOI":"10.1016\/j.regpep.2004.08.024"},{"key":"10.1124\/jpet.105.093104_bib26","doi-asserted-by":"crossref","unstructured":"Theodorsson-Norheim E (1987) Friedman and Quade tests: BASIC computer program to perform nonparametric two-way analysis of variance and multiple comparisons on ranks of several related samples. Comput Biol Med 17: 85-99.","DOI":"10.1016\/0010-4825(87)90003-5"},{"key":"10.1124\/jpet.105.093104_bib27","doi-asserted-by":"crossref","unstructured":"Vila Petroff MG, Egan JM, Wang X, and Sollott SJ (2001) Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res 89: 445-452.","DOI":"10.1161\/hh1701.095716"},{"key":"10.1124\/jpet.105.093104_bib28","doi-asserted-by":"crossref","unstructured":"Woolard J, Bennett T, Dunn WR, Heal DJ, Aspley S, and Gardiner SM (2004) Acute cardiovascular effects of sibutramine in conscious rats. J Pharmacol Exp Ther 308: 1102-1110.","DOI":"10.1124\/jpet.103.061259"},{"key":"10.1124\/jpet.105.093104_bib29","doi-asserted-by":"crossref","unstructured":"Yamamoto H, Kishi T, Lee CE, Choi BJ, Fang H, Hollenberg AN, Drucker DJ, and Elmquist JK (2003) Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic sites. J Neurosci 23: 2939-2946.","DOI":"10.1523\/JNEUROSCI.23-07-02939.2003"},{"key":"10.1124\/jpet.105.093104_bib30","doi-asserted-by":"crossref","unstructured":"Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB, Drucker DJ, et al. (2002) Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Investig 110: 43-52.","DOI":"10.1172\/JCI0215595"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652432498X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652432498X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.093104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:45:37Z","timestamp":1740001537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652432498X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S002235652432498X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.093104","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenteric Vasoconstriction and Hindquarters Vasodilatation Accompany the Pressor Actions of Exendin-4 in Conscious Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.093104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}